Literature DB >> 15516479

Concurrent granulomatous Pneumocystis carinii and Mycobacterium xenopi pneumonia: an unusual manifestation of HIV immune reconstitution disease.

F Chen1, G Sethi, R Goldin, A R Wright, C J Lacey.   

Abstract

This report of concurrent granulomatous Pneumocystis carinii pneumonia (GPCP) and Mycobacterium xenopi pneumonia (MXIP) in a patient with advanced HIV disease 3-5 weeks after commencing antiretroviral therapy (ART) fits the syndrome of HIV immune reconstitution/restoration disease (IRD). It may also be a unique window into the immunology of granulomatous inflammation.

Entities:  

Mesh：

Year:  2004        PMID： 15516479      PMCID： PMC1746867          DOI： 10.1136/thx.2003.012567

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


  4 in total

1.  CD8 T cells modulate CD4 T-cell and eosinophil-mediated pulmonary pathology in pneumocystis pneumonia in B-cell-deficient mice.

Authors:  Steve D Swain; Nicole N Meissner; Allen G Harmsen
Journal:  Am J Pathol       Date:  2006-02       Impact factor: 4.307

2.  Granulomatous Pneumocystis jiroveci pneumonia associated with immune reconstituted HIV.

Authors:  Natasha Sabur; Margaret M Kelly; M John Gill; Martha D Ainslie; Sachin R Pendharkar
Journal:  Can Respir J       Date:  2011 Nov-Dec       Impact factor: 2.409

3.  Acute microbiologically negative hypoxic interstitial pneumonia on HAART: Immune Reconstitution Inflammatory Syndrome unmasking Pneumocystis jiroveci infection with an atypical presentation.

Authors:  S Sovaila; A de Raigniac; C Picard; O Taulera; C Lascoux-Combe; D Sereni; A Bourgarit
Journal:  J Med Life       Date:  2012-06-18

4.  Unmasking Granulomatous Pneumocystis jirovecii Pneumonia with Nodular Opacity in an HIV-Infected Patient after Initiation of Antiretroviral Therapy.

Authors:  Hyung Woo Kim; Jung Yeon Heo; Yong Moon Lee; S J Kim; Hye Won Jeong
Journal:  Yonsei Med J       Date:  2016-07       Impact factor: 2.759
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.